Wang Xiaodong 4

Accession 0001651308-25-000080

CIK 0001651308other

View on SEC.gov Company Profile

Filed

May 14, 8:00 PM ET

Accepted

May 15, 5:37 PM ET

Size

18.0 KB

Accession

0001651308-25-000080

Insider Transaction Report

Form 4

Period: 2025-05-13

BeiGene, Ltd.BGNE

Wang Xiaodong

DirectorOther

Transactions

Sale
American Depositary Shares
2025-05-13$222.83/sh−10,221$2,277,501→ 31,539 total
Sale
American Depositary Shares
2025-05-13$224.32/sh−10,104$2,266,542→ 200 total
Exercise/Conversion
American Depositary Shares
2025-05-13$6.50/sh+41,760$271,440→ 41,760 total
Sale
American Depositary Shares
2025-05-13$223.41/sh−21,235$4,744,092→ 10,304 total
Sale
American Depositary Shares
2025-05-13$225.68/sh−200$45,136→ 0 total
Exercise/Conversion
Share Option (Right to Buy)
2025-05-13−542,880→ 542,887 total
Exercise: $0.50Exp: 2025-07-19→ Ordinary Shares (542,880 underlying)

Holdings

Ordinary Shares
5,082,165
Ordinary Shares
(indirect: See Footnote)
1,025,063
Ordinary Shares
(indirect: See Footnote)
3,953,100
Ordinary Shares
(indirect: See Footnote)
50

Footnotes (9)

[F1]These securities are held by a family trust, the beneficiaries of which are the Reporting Person's family members, for which the Reporting Person disclaims beneficial ownership.
[F2]These securities are held by Wang Investment LLC, of which 99% of the limited liability company interest is owned by two grantor retained annuity trusts, of which the Reporting Person's wife is a trustee, for which the Reporting Person disclaims beneficial ownership.
[F3]These securities are held by the spouse of the Reporting Person.
[F4]Each American Depositary Share represents 13 Ordinary Shares.
[F5]The sale was effected pursuant to a Rule 10b5-1 trading plan adopted on August 12, 2024.
[F6]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $222.03 to $223.02, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.
[F7]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $223.03 to $224.02, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.
[F8]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $224.03 to $224.77, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.
[F9]These securities vest over a five-year period as follows: 20% on July 19, 2016, and the remaining in 48 successive equal monthly installments, subject to continued service. The expiration date of the share option is July 19, 2025.

Documents

1 file

4
wk-form4_1747345071.xmlPrimary
FORM 4

Issuer

BeiGene, Ltd.

CIK 0001651308

→

Entity typeother

Related Parties

filerCIK 0001662982

Filing Metadata

Form type: 4
Filed: May 14, 8:00 PM ET
Accepted: May 15, 5:37 PM ET
Size: 18.0 KB

View on SEC.gov